Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14758 | 682 | 28.9 | 58% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BAMBUTEROL | Author keyword | 24 | 68% | 3% | 21 |
2 | NOCTURNAL ASTHMA | Author keyword | 20 | 44% | 5% | 35 |
3 | JAMES B SKATRUD PULM SLEEP | Address | 9 | 83% | 1% | 5 |
4 | SLEEP MED SLEEP WISCONSIN SLEEP | Address | 4 | 75% | 0% | 3 |
5 | R BAMBUTEROL | Author keyword | 2 | 67% | 0% | 2 |
6 | YALE SLEEP DISORDERS | Address | 2 | 67% | 0% | 2 |
7 | TULOBUTEROL | Author keyword | 2 | 26% | 1% | 5 |
8 | PEAK EXPIRATORY FLOW VARIABILITY | Author keyword | 1 | 38% | 0% | 3 |
9 | BIOSTAT MED INFORMAT POPULAT HLTH SCI | Address | 1 | 100% | 0% | 2 |
10 | ORAL BETA2 AGONIST | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BAMBUTEROL | 24 | 68% | 3% | 21 | Search BAMBUTEROL | Search BAMBUTEROL |
2 | NOCTURNAL ASTHMA | 20 | 44% | 5% | 35 | Search NOCTURNAL+ASTHMA | Search NOCTURNAL+ASTHMA |
3 | R BAMBUTEROL | 2 | 67% | 0% | 2 | Search R+BAMBUTEROL | Search R+BAMBUTEROL |
4 | TULOBUTEROL | 2 | 26% | 1% | 5 | Search TULOBUTEROL | Search TULOBUTEROL |
5 | PEAK EXPIRATORY FLOW VARIABILITY | 1 | 38% | 0% | 3 | Search PEAK+EXPIRATORY+FLOW+VARIABILITY | Search PEAK+EXPIRATORY+FLOW+VARIABILITY |
6 | ORAL BETA2 AGONIST | 1 | 100% | 0% | 2 | Search ORAL+BETA2+AGONIST | Search ORAL+BETA2+AGONIST |
7 | PEAK EXPIRATORY FLOW VARIATION | 1 | 50% | 0% | 2 | Search PEAK+EXPIRATORY+FLOW+VARIATION | Search PEAK+EXPIRATORY+FLOW+VARIATION |
8 | NOCTURNAL SYMPTOMS | 1 | 27% | 0% | 3 | Search NOCTURNAL+SYMPTOMS | Search NOCTURNAL+SYMPTOMS |
9 | BETA 2 MIMETICS | 1 | 50% | 0% | 1 | Search BETA+2+MIMETICS | Search BETA+2+MIMETICS |
10 | BETA2 RECEPTOR POLYMORPHISM | 1 | 50% | 0% | 1 | Search BETA2+RECEPTOR+POLYMORPHISM | Search BETA2+RECEPTOR+POLYMORPHISM |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NOCTURNAL ASTHMA | 34 | 27% | 16% | 107 |
2 | SUSTAINED RELEASE THEOPHYLLINE | 6 | 31% | 2% | 17 |
3 | SLOW RELEASE TERBUTALINE | 4 | 75% | 0% | 3 |
4 | DECREASED STEROID RESPONSIVENESS | 4 | 56% | 1% | 5 |
5 | DAYTIME COGNITIVE PERFORMANCE | 3 | 45% | 1% | 5 |
6 | BAMBUTEROL | 3 | 30% | 1% | 8 |
7 | RECURRENT NOCTURNAL ASTHMA | 2 | 67% | 0% | 2 |
8 | HYPOXIA SUPPRESSES | 2 | 50% | 0% | 3 |
9 | CLINICAL CHRONOBIOLOGY | 1 | 100% | 0% | 2 |
10 | EXPIRATORY FLOW VARIATION | 1 | 100% | 0% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma | 2007 | 59 | 159 | 41% |
Clinical pharmacokinetics of bambuterol | 1996 | 24 | 35 | 89% |
Nocturnal asthma | 2012 | 7 | 45 | 40% |
Asthma: Chronopharmacotherapy and the molecular clock | 2010 | 23 | 101 | 31% |
Obstructive sleep apnea and asthma: Associations and treatment implications | 2014 | 6 | 91 | 21% |
Integrating the overlap of obstructive lung disease and obstructive sleep apnoea: OLDOSA syndrome | 2013 | 10 | 99 | 21% |
Nocturnal asthma | 2005 | 39 | 43 | 51% |
Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma | 2002 | 8 | 3 | 100% |
Nocturnal worsening of asthma and sleep-disordered breathing | 2002 | 31 | 89 | 42% |
Asthma and Obstructive Sleep Apnea: Clinical and Pathogenic Interactions | 2014 | 4 | 137 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JAMES B SKATRUD PULM SLEEP | 9 | 83% | 0.7% | 5 |
2 | SLEEP MED SLEEP WISCONSIN SLEEP | 4 | 75% | 0.4% | 3 |
3 | YALE SLEEP DISORDERS | 2 | 67% | 0.3% | 2 |
4 | BIOSTAT MED INFORMAT POPULAT HLTH SCI | 1 | 100% | 0.3% | 2 |
5 | WISCONSIN SLEEP | 1 | 50% | 0.3% | 2 |
6 | BERNSTEIN CLIN | 1 | 50% | 0.1% | 1 |
7 | INTER MED SCI PROGRAM | 1 | 50% | 0.1% | 1 |
8 | IST RIABIL | 1 | 50% | 0.1% | 1 |
9 | JOHN RANKIN PULM | 1 | 50% | 0.1% | 1 |
10 | KLIN FOR ABT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179465 | CAS 58 55 9//ABT BIOPHARM PHARMAKOKINETIK//BRONCHORETARD R |
2 | 0.0000134349 | OXATOMIDE//AL 3264//PROCATEROL |
3 | 0.0000103514 | METHACHOLINE INHALATION CHALLENGE//BRONCHIAL HYPERRESPONSIVENESS//METHACHOLINE |
4 | 0.0000101450 | FORMOTEROL//SALMETEROL//BUDESONIDE FORMOTEROL |
5 | 0.0000091583 | CLENBUTEROL//TRANTINTEROL//BETA AGONISTS |
6 | 0.0000088909 | SPIROMETRY//PEAK FLOW METERS//REFERENCE EQUATIONS |
7 | 0.0000086914 | LONG TERM OXYGEN THERAPY//AMBULATORY OXYGEN//SLEEP RELATED HYPOXAEMIA |
8 | 0.0000080799 | PROPRANOLOL INDUCED BRONCHOCONSTRICTION//MED FELS CANC MOL BIOL//ALLERGIC BRONCHOCONSTRICTION |
9 | 0.0000077346 | DOXOFYLLINE//ENPROFYLLINE//3H IMIDAZO4 5 CQUINOLIN 45H ONE |
10 | 0.0000076239 | FREUNDS ADJUVANT ARTHRITIS//CHRONOPHARMACOLOGY//CHRONOTOXICITY |